84 related articles for article (PubMed ID: 17096889)
1. [Migration and distribution of allogeneic T lymphocytes in organs of graft-versus-host disease mouse model].
Wen HS; Wang JM; Zhou H; Xia R; Qiu HY; Gao L; Hu XX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):919-23. PubMed ID: 17096889
[TBL] [Abstract][Full Text] [Related]
2. Migration and activation of T cells during development of graft-versus-host disease in a mouse model.
Wen HS; Wang JM; Zhou H; Gong SI; Gao L; Wu Y
Transplant Proc; 2013 Mar; 45(2):713-8. PubMed ID: 23498811
[TBL] [Abstract][Full Text] [Related]
3. T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8(+) T cells to the liver, lung, and spleen during graft-versus-host disease.
Serody JS; Burkett SE; Panoskaltsis-Mortari A; Ng-Cashin J; McMahon E; Matsushima GK; Lira SA; Cook DN; Blazar BR
Blood; 2000 Nov; 96(9):2973-80. PubMed ID: 11049973
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation.
Shankar G; Bryson JS; Jennings CD; Morris PE; Cohen DA
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):235-42. PubMed ID: 9476911
[TBL] [Abstract][Full Text] [Related]
5. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
[TBL] [Abstract][Full Text] [Related]
6. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets.
Lu X; Liu T; Gu L; Huang C; Zhu H; Meng W; Xi Y; Li S; Liu Y
Transpl Immunol; 2009 Dec; 22(1-2):55-61. PubMed ID: 19695330
[TBL] [Abstract][Full Text] [Related]
8. Control of mouse graft-versus-host disease following allogeneic bone marrow transplantation by blocking the CD28/B7 signaling pathway with lentiviral vector-mediated RNA interference.
Sang W; Zhou C; Cheng N; Li Z; Zeng L; Xu K
Immunol Lett; 2011 May; 136(2):194-202. PubMed ID: 21277900
[TBL] [Abstract][Full Text] [Related]
9. Bioimaging for the monitoring of the in vivo distribution of infused mesenchymal stem cells in a mouse model of the graft-versus-host reaction.
Joo SY; Cho KA; Jung YJ; Kim HS; Park SY; Choi YB; Hong KM; Woo SY; Seoh JY; Ryu KH
Cell Biol Int; 2011 Apr; 35(4):417-21. PubMed ID: 21062262
[TBL] [Abstract][Full Text] [Related]
10. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
[TBL] [Abstract][Full Text] [Related]
11. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
Zhao J; Zhao XY; Huang XJ
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
[TBL] [Abstract][Full Text] [Related]
12. Differential Effects of Gut-Homing Molecules CC Chemokine Receptor 9 and Integrin-β7 during Acute Graft-versus-Host Disease of the Liver.
Schreder A; Moschovakis GL; Halle S; Schlue J; Lee CW; Schippers A; David S; Bernhardt G; Ganser A; Pabst O; Förster R; Koenecke C
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2069-2078. PubMed ID: 26348893
[TBL] [Abstract][Full Text] [Related]
13. Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation.
Radhakrishnan SV; Palaniyandi S; Mueller G; Miklos S; Hager M; Spacenko E; Karlsson FJ; Huber E; Kittan NA; Hildebrandt GC
Biol Blood Marrow Transplant; 2015 Jan; 21(1):30-8. PubMed ID: 25445642
[TBL] [Abstract][Full Text] [Related]
14. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
[TBL] [Abstract][Full Text] [Related]
15. Induction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model.
Nagler A; Ohana M; Alper R; Doviner V; Sherman Y; Rabbani E; Engelhardt D; Ilan Y
Bone Marrow Transplant; 2003 Aug; 32(4):363-9. PubMed ID: 12900772
[TBL] [Abstract][Full Text] [Related]
16. Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after murine bone marrow transplantation across minor histocompatibility antigen barriers.
Eyrich M; Burger G; Marquardt K; Budach W; Schilbach K; Niethammer D; Schlegel PG
Biol Blood Marrow Transplant; 2005 May; 11(5):371-82. PubMed ID: 15846291
[TBL] [Abstract][Full Text] [Related]
17. Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes.
Margalit M; Ilan Y; Ohana M; Safadi R; Alper R; Sherman Y; Doviner V; Rabbani E; Engelhardt D; Nagler A
Bone Marrow Transplant; 2005 Jan; 35(2):191-7. PubMed ID: 15558045
[TBL] [Abstract][Full Text] [Related]
18. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
19. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
[TBL] [Abstract][Full Text] [Related]
20. [An absence of donor TH17 differentiation ameliorates dermal tissue damage].
Cheng H; Song GL; Pan B; Tian J; Yan ZL; Chen W; Xu KL; Li ZY; Zeng LY
Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(26):1843-6. PubMed ID: 22093788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
